Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-18
DOI
10.3389/fmolb.2022.834453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Highly accurate protein structure prediction with AlphaFold
- (2021) John Jumper et al. NATURE
- Accurate prediction of protein structures and interactions using a three-track neural network
- (2021) Minkyung Baek et al. SCIENCE
- The Effect of Training and Testing Process on Machine Learning in Biomedical Datasets
- (2020) Muhammed Kürşad Uçar et al. MATHEMATICAL PROBLEMS IN ENGINEERING
- Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
- (2020) Brooke Benner et al. Drug Design Development and Therapy
- Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors
- (2020) Malikotsi A. Qhobosheane et al. BIOORGANIC & MEDICINAL CHEMISTRY
- CcpNmr AnalysisScreen, a new software programme with dedicated automated analysis tools for fragment-based drug discovery by NMR
- (2020) Luca G. Mureddu et al. JOURNAL OF BIOMOLECULAR NMR
- Applications of In-Cell NMR in Structural Biology and Drug Discovery
- (2019) CongBao Kang INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Simple high-resolution NMR spectroscopy as a tool in molecular biology
- (2019) Luca Mureddu et al. FEBS Journal
- Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity
- (2019) Zoltan Szlávik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
- (2019) Richard W. Birkinshaw et al. Nature Communications
- Exposing Small-Molecule Nanoentities by a Nuclear Magnetic Resonance Relaxation Assay
- (2019) Yann Ayotte et al. JOURNAL OF MEDICINAL CHEMISTRY
- 7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors
- (2018) Takayuki Irie et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- NMR-Fragment Based Virtual Screening: A Brief Overview
- (2018) et al. MOLECULES
- Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy
- (2018) Alexandra Primikyri et al. FEBS LETTERS
- Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
- (2018) Joseph Schoepfer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS
- (2017) Stephen J. Capuzzi et al. Journal of Chemical Information and Modeling
- Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
- (2017) Timothy P.S. Perera et al. MOLECULAR CANCER THERAPEUTICS
- Weak-binding molecules are not drugs?—toward a systematic strategy for finding effective weak-binding drugs
- (2016) Jinan Wang et al. BRIEFINGS IN BIOINFORMATICS
- Fragment-based Drug Discovery: Lessons and Outlook . Edited by Daniel A. Erlanson and Wolfgang Jahnke; Series Editors: Raimund Mannhold, Hugo Kubinyi, and Gerd Folkers
- (2016) David Rees ChemMedChem
- Venetoclax: First Global Approval
- (2016) Emma D. Deeks DRUGS
- CcpNmr AnalysisAssign: a flexible platform for integrated NMR analysis
- (2016) Simon P. Skinner et al. JOURNAL OF BIOMOLECULAR NMR
- BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics
- (2016) R. S. Soderquist et al. MOLECULAR CANCER THERAPEUTICS
- Twenty years on: the impact of fragments on drug discovery
- (2016) Daniel A. Erlanson et al. NATURE REVIEWS DRUG DISCOVERY
- X-ray crystallography over the past decade for novel drug discovery – where are we heading next?
- (2015) Heping Zheng et al. Expert Opinion on Drug Discovery
- Ligand-Orientation Based Fragment Selection in STD NMR Screening
- (2015) Olivier Cala et al. JOURNAL OF MEDICINAL CHEMISTRY
- Beware of docking!
- (2015) Yu-Chian Chen TRENDS IN PHARMACOLOGICAL SCIENCES
- MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
- (2015) G S Choudhary et al. Cell Death & Disease
- Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
- (2015) Dávid Bajusz et al. Journal of Cheminformatics
- Comparison of the sensitivities of WaterLOGSY and saturation transfer difference NMR experiments
- (2014) Aleksandar Antanasijevic et al. JOURNAL OF BIOMOLECULAR NMR
- Beware of Machine Learning-Based Scoring Functions—On the Danger of Developing Black Boxes
- (2014) Joffrey Gabel et al. Journal of Chemical Information and Modeling
- Development of Dual Inhibitors against Alzheimer’s Disease Using Fragment-Based QSAR and Molecular Docking
- (2014) Manisha Goyal et al. Biomed Research International
- Learning from our mistakes: The ‘unknown knowns’ in fragment screening
- (2013) Ben J. Davis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia
- (2013) C. J. Vandenberg et al. BLOOD
- Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases
- (2013) Matt Addie et al. JOURNAL OF MEDICINAL CHEMISTRY
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Using chemical shift perturbation to characterise ligand binding
- (2013) Mike P. Williamson PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
- Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
- (2012) Fredrik Jeppsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides
- (2012) Britt-Marie Swahn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
- (2011) Tina C. Albershardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Saturation-Transfer Difference (STD) NMR: A Simple and Fast Method for Ligand Screening and Characterization of Protein Binding
- (2011) Aldino Viegas et al. JOURNAL OF CHEMICAL EDUCATION
- Developing β-secretase inhibitors for treatment of Alzheimer’s disease
- (2011) Arun K. Ghosh et al. JOURNAL OF NEUROCHEMISTRY
- Vemurafenib
- (2011) Keith. T Flaherty et al. NATURE REVIEWS DRUG DISCOVERY
- 2D TR-NOESY Experiments Interrogate and Rank Ligand-Receptor Interactions in Living Human Cancer Cells
- (2010) Silvia Mari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR
- (2010) Andrew M. Petros et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting biomolecular flexibility with metadynamics
- (2010) Vanessa Leone et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- NMR Screening and Hit Validation in Fragment Based Drug Discovery
- (2010) Ramon Campos-Olivas CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Chemical space as a source for new drugs
- (2010) Jean-Louis Reymond et al. MedChemComm
- A Multi-Step NMR Screen for the Identification and Evaluation of Chemical Leads for Drug Discovery
- (2009) Kelly Mercier et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- The -Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
- (2009) R. Vassar et al. JOURNAL OF NEUROSCIENCE
- Accurate characterization of weak macromolecular interactions by titration of NMR residual dipolar couplings: application to the CD2AP SH3-C:ubiquitin complex
- (2009) Jose Luis Ortega-Roldan et al. NUCLEIC ACIDS RESEARCH
- Beta-Secretase: Structure, Function, and Evolution
- (2008) Chitra Venugopal et al. CNS & Neurological Disorders-Drug Targets
- Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization
- (2008) Fabian Dey et al. Journal of Chemical Information and Modeling
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started